New method of immunotherapy delivery lowers pain in children with high-risk neuroblastoma
In children with high-risk relapsed/refractory neuroblastoma, long-term infusion (LTI) of the antibody ch14.18/CHO (dinutuximab-beta; the European counterpart of dinutuximab) in combination with other drugs lowered neuropathic ...
Sep 17, 2015
0
143